ACell expands MatriStem pelvic floor matrix product portfolio with addition of four device sizes
Columbia, Md. - ACell Inc., a leading regenerative medicine company focused on the development, manufacturing, and commercialization of tissue repair products, today announced that it has expanded the MatriStem Pelvic Floor Matrix product portfolio with the addition of four device sizes. The addition of four new sizes to the portfolio offers a broad range of viable solutions for physicians treating patients in need of pelvic floor repair.
MatriStem Pelvic Floor Matrix is a naturally-occurring, non-synthetic scaffold that provides a unique balance of strength and pliability for use in repair of anterior, posterior and apical defects. Comprised of proprietary Urinary Bladder Matrix (UBM), MatriStem Pelvic Floor Matrix is intended for implantation to reinforce soft tissue where weakness exists in urological and gynecological anatomy including vaginal prolapse repair, reconstruction of pelvic floor, and pubourethral support.
On the market since 2010, MatriStem Pelvic Floor Matrix is currently available in 9cm x 9cm x 12cm (trapezoid) size, with four new sizes being added to the product line: 5cm x 5cm, 4cm x 12cm, 7cm x 10cm and 10cm x 15cm.
Rodney Bosley, president of ACell, remarks, "ACell has extended the MatriStem Pelvic Floor Matrix product portfolio with the addition of four sizes to provide a series of viable options for physicians treating patients requiring pelvic floor repair. We have seen a growing demand by physicians for devices that promote the formation of site-specific tissue and restore form through constructive remodeling. Our goal continues to be improving the lives of patients through offering effective tissue repair products."
MatriStem products are medical devices that maintain and support a healing environment through constructive remodeling. Composed of naturally-occurring UBM, MatriStem maintains an intact epithelial basement membrane and facilitates the body's ability to form site specific tissue.
ACell, Inc. offers the next generation of regenerative medicine through the development and commercialization of unique extracellular matrix (ECM) products to repair and remodel damaged tissues in a broad range of applications. Its patented MatriStem ECM medical devices maintain and support a healing environment through constructive remodeling and are available in particle and sheet forms for the treatment of acute wounds and various surgical procedures. For more information, visit www.acell.com.
Source: ACell Inc.